Dataset from A Phase IIIb, 24-week, Randomised, Placebo-controlled, Double-blinded, Efficacy and Safety Study of Linagliptin (BI 1356) in Black/African American Patients With Type 2 Diabetes With a MTT Sub-study

Name: Dataset from A Phase IIIb, 24-week, Randomised, Placebo-controlled, Double-blinded, Efficacy and Safety Study of Linagliptin (BI 1356) in Black/African American Patients With Type 2 Diabetes With a MTT Sub-study
Creator: 暂无描述
License: 暂无描述

NIAID Data Ecosystem2026-05-10 收录

下载链接：

https://doi.org/10.25934/00003618

下载链接

链接失效反馈

官方服务：

资源简介：

Study of linagliptin vs. placebo in Black/African American patients with T2DM with a MTT sub-study

创建时间：

2025-12-08